Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04093596
Title Safety and Efficacy of ALLO-715 BCMA Allogenic CAR T Cells in in Adults With Relapsed or Refractory Multiple Myeloma (UNIVERSAL) (UNIVERSAL)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Allogene Therapeutics
Indications

multiple myeloma

Therapies

ALLO-647 + ALLO-715

ALLO-647 + ALLO-715 + Cyclophosphamide + Fludarabine

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.